Richard Sherman

Secrétaire Général chez TETRALOGIC PHARMACEUTICALS CORPORATION

Profil

Richard L.
Sherman was the founder of QED Technologies LP, founded in 1992, where the title held was Managing Officer from 1992 to 2001.
Current jobs include Venture Partner at SCP Private Equity Partners and Secretary at TetraLogic Pharmaceuticals Corp.
since 2012.
Former jobs include Non-Executive Chairman at Functional Technologies Corp.
from 2012 to 2013; Director & General Counsel at Hawaii Biotech, Inc. from 2014 to 2015; Independent Director at Immunomedics, Inc. from 2013 to 2015; Director at Sparta Pharmaceuticals, Inc., Mera Pharmaceuticals, Inc., IBAH, Inc., Biophage Pharma, Inc., CytoMed, Inc., Kenna Technologies, Inc., and Life Sciences Pennsylvania; Director at Leversense LLC from 2011 to 2013; Partner at Pepper Hamilton LLP in 1992; Secretary & General Counsel at Actinium Pharmaceuticals, Inc. from 2004 to 2013; Deputy General Counsel at Smithkline Beckman Corp from 1976 to 1989; Venture Partner at SCP Vitalife Partners; and Vice President at Malvern Consulting Group, Inc. Education includes undergraduate degree from the University of Nebraska in 1968 and graduate degree from New York University in 1971.

Postes actifs de Richard Sherman

Sociétés	Poste	Début
TETRALOGIC PHARMACEUTICALS CORPORATION	Secrétaire Général	01/11/2012
SCP Private Equity Partners	Private Equity Investor	-

Anciens postes connus de Richard Sherman

Sociétés	Poste	Fin
IMMUNOMEDICS, INC.	Directeur/Membre du Conseil	02/12/2015
FUNCTIONAL TECHNOLOGIES CORP	Président	25/06/2013
Actinium Pharmaceuticals, Inc. /Old/	Conseiller Juridique Général	18/04/2013
Leversense LLC	Directeur/Membre du Conseil	01/02/2013
QED Technologies LP	Fondateur	01/01/2001